Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-0524-2027

R3FLEX Stabilization System Grappler Suture Anchor System REF:: P82-001-1237-SK Recall

R3FLEX Stabilization System Grappler Suture Anchor System REF:: P82-001-1237-SK

FDA recall Class II

Open , Classified

FDA lists this Class II recall for R3FLEX Stabilization System Grappler Suture Anchor System REF:: P82-001-1237-SK. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-0524-2027
Recall classification
Class II
FDA database status
Open , Classified
Initiation date
Oct 12, 2026
FDA website posting date
Nov 20, 2026
Quantity in commerce
448 units
Distribution
See key details
FDA cause
Not reported

What is being recalled?

R3FLEX Stabilization System Grappler Suture Anchor System REF:: P82-001-1237-SK

Affected model & UDI checker

Search the exact identifiers published for Z-0524-2027.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
Not specifiedR3FLEX Stabilization System Grappler Suture Anchor System REF:: P82-001-1237-SKCheck source notice00889795128140
FDA code information

UDI: (01)00889795128140/Label Lot Number: 946160817626/ Electronic Lot Number: 6160817626;Label Lot Number: 946160918126/ Electronic Lot Number: 6160918126

View the original FDA recall notice

Why was this product recalled?

Suture Anchor system lacks pre-tied knot which could result in the anchor assembly not properly holding tension.

These are potential consequences described in the source. The recall reason does not establish how many injuries or incidents occurred.

What actions did Paragon 28, Inc. take?

On October 12, 2026, Paragon 28 (a Zimmer Biomet Company) issued a Urgent Medical Device Recall Notification via: FedEx, 2nd Day Delivery : 1. Review this notification and ensure that affected team members are aware of the contents. 2. Immediately locate and quarantine affected product in your inventory. 3. Immediately return all affected product from your distributorship and from affected hospitals within your territory. a. Complete the Inventory Return Certification Form for each return and send to [email protected]. This form must be returned even if you do not have affected products available to return in your territory. 4. Return the Additional Accounts form to [email protected]. 5.Retain a copy of your Inventory Return Certification and product return forms for your records in the event of a compliance audit of your facility. 6. If you have further questions or concerns after reviewing this notice, please call 888-728-1888. Alternatively, your questions may be emailed to [email protected].

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology